LifeMD (LifeMD) Interest Expense : $-2.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is LifeMD Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. LifeMD's interest expense for the three months ended in Mar. 2024 was $ -0.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. LifeMD's Operating Income for the three months ended in Mar. 2024 was $ -6.2 Mil. LifeMD's Interest Expense for the three months ended in Mar. 2024 was $ -0.5 Mil. LifeMD did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LifeMD Interest Expense Historical Data

The historical data trend for LifeMD's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeMD Interest Expense Chart

LifeMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.76

-1.67

-3.02

-1.28

-2.60

LifeMD Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.26	-1.00	-0.71	-0.62	-0.48

LifeMD Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.8 Mil.

LifeMD (NAS:LFMD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LifeMD's Interest Expense for the three months ended in Mar. 2024 was $-0.5 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-6.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $15.4 Mil.

LifeMD's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

LifeMD did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

LifeMD (LifeMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeMD Inc (NAS:LFMD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

236 Fifth Avenue, Suite 400, Fourth Floor, New York, NY, USA, 10001

Website

https://www.lifemd.com

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Executives

Bertrand Velge	director	BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND, ROMNEY MARSH, KENT X0 TN299TR
William J Febbo	director, other: Consultant	600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Nicholas P Alvarez	officer: Chief Acquisition Officer	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Eric Harold Yecies	officer: CCO and General Counsel	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Brad Michael Roberts	officer: Chief Operating Officer	300 CHAFFORD COURT, SIMPSONVILLE SC 29681
Justin Schreiber	director, 10 percent owner, officer: President, Immudyne PR	236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Stefan Galluppi	director, officer: Chief Operating Officer	C/O LIFEMD, INC, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joan Larovere	director	C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Jessica Friedeman	officer: Chief Marketing Officer	C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Kathleen E Walsh	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Piyush Jindal	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joseph Ditrolio	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Maria E. Stan	officer: Principal Accounting Officer	236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Dennis Wijnker	officer: Chief Technology Officer	536 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Naveen Bhatia	director	823 GREENTREE RD, PACIFIC PALISADES CA 90272